Search

everythinglearnresearchcommunity

for

Search:↓

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

The method identified and measured ten compounds from Eclipta prostrata, showing significant enzyme inhibitory effects.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Long use of finasteride and dutasteride can cause long-term erection problems.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride may reduce prostate cancer risk.

The methods accurately measure Finasteride and Tamsulosin in tablets.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

Setipiprant did not significantly improve hair growth in men with hair loss.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Finasteride blocks progesterone's effect on absence seizures in rats.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

The nano-carrier makes etoposide safer and more effective against lung cancer.